Prostate Cancer Screening Recommended Only for High-Risk Men with BRCA2 Gene Variant
Auf einen Blick
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.
KI-generierte Zusammenfassung
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.




